IPO registrations (S-1, F-1) · Registrants
VIVUS INC
- SEC CIK
- 881524 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2020-06-08, last 2020-06-19; 2 initial registrations, 1 amendment
- Outcome
- Declared effective 2020-12-30; withdrawal requested 2020-12-29
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 900 E. HAMILTON AVENUE, SUITE 550, Campbell, CA 95008
- EIN
- 94-3136179
- EDGAR entity type
- operating
- Insiders and CEO pay
- VIVUS INC on the corporate pages
Offering terms
- Shares offered
- 154,867,256
- Listing
- Nasdaq under the symbol VVUS
- Lead underwriters
- Warrant and
- Syndicate
- H.C. Wainwright
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Vivus Limited Fuzzy (name and state)
- Business registration: VIVUS LLC Fuzzy (name and state)
- Form 5500 plan sponsor: VIVUS LLC EXACT (EIN (EXACT))
- Federal award recipient: VIVUS LLC Fuzzy (name and state)
- Lobbying client: VIVUS INC Fuzzy (name and state)
- Lobbying client: VIVUS INC Fuzzy (name and state)
- Lobbying client: VIVUS INC. Fuzzy (name and state)
- Lobbying client: VIVUS, INC. Fuzzy (name and state)
- SEC filer: VIVUS INC EXACT (CIK (EXACT))
- Person page: Eric W Roberts Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Johann Noor Mohamed Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Samuel F Colin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-06-08 | S-1 | S-1 (registration) | VIVUS INC | 0001047469-20-003425 ↗ |
| 2020-06-09 | S-1 | S-1 (registration) | VIVUS INC | 0001047469-20-003427 ↗ |
| 2020-06-19 | S-1/A | S-1/A (amendment) | VIVUS INC | 0001047469-20-003720 ↗ |
| 2020-12-29 | RW | RW (withdrawal request) | VIVUS INC | 0001104659-20-140201 ↗ |
| 2020-12-29 | RW | RW (withdrawal request) | VIVUS INC | 0001104659-20-140203 ↗ |
| 2020-12-30 | EFFECT | EFFECT (declared effective) | VIVUS INC | 9999999995-20-003691 ↗ |
| 2020-12-30 | EFFECT | EFFECT (declared effective) | VIVUS INC | 9999999995-20-003692 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-19 | S-1/A | registration statement | 154,867,256 | - | Nasdaq VVUS | 2 | primary document; shares headline, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Day Wesley | Officer | VP, Clinical Development; VP, Clinical Research | 27 | 2006–2016 | |
| DIETRICH JOHN W | Officer | Vice President, R & D; Vice President, R&D | 4 | 2006–2007 | |
| LOGAN MARK B | Director | 24 | 2006–2013 | ||
| MARSH GUY P | Officer; OfficerOther | VP, Operations and General Mgr; VP, Operations & General Mgr; VP, Operations & General Mgr.; VP, U.S. Operations & GM; VP, US Operations & GM | 31 | 2006–2016 | |
| MORRIS TIMOTHY E | Officer | SVP, Finance and CFO; SVP, Finance & CFO; VP, Finance and CFO; VP, Finance & CFO | 12 | 2006–2013 | |
| NIDA TERRY | Officer | VP, Worldwide Marketing/; VP, Worldwide Mktg/Corp Dvlop | 4 | 2006–2007 | |
| PLACE VIRGIL A | Director,Officer; Officer | Chairman & CSO; Cheif Scientific Officer; Chief Scientific Officer | 16 | 2006–2010 | |
| ROSATI MARIO M | Director; Director,Officer | Secretary | 7 | 2006–2008 | |
| SHORTLIFFE LINDA M DAIRIKI | Director | 23 | 2006–2013 | ||
| STRACHAN GRAHAM | Director | 12 | 2006–2010 | ||
| TAM PETER Y | Director,Officer; Officer | Chief Operating Officer; President; Senior VP, Product &; SVP, Product & Corporate Dev. | 24 | 2006–2013 | |
| WILSON LELAND F | Director; Director,Officer | CEO; Chief Executive Officer; President and CEO; President & CEO | 41 | 2006–2013 | |
| Changjin Wang | Officer | VP, Business Development | 4 | 2006–2008 | |
| Perry Lee | Officer | Vice President & Chief; VP & Chief Accounting Officer | 10 | 2007–2013 | |
| CASAMENTO CHARLES J | Director | 16 | 2008–2013 | ||
| Slebir John L | Officer | General Counsel & Asst. Sec.; SVP, Business Development & GC; SVP, Business Dev., GC; SVP & General Counsel; VP & General Counsel; VP, General Counsel | 23 | 2009–2020 | |
| MILLER MICHAEL PATRICK | Officer | Chief Commercial Officer; SVP, Chief Commercial Officer | 8 | 2010–2013 | |
| MILLER MICHAEL /NY/ | Officer | Chief Commercial Officer | 1 | 2012 | |
| MARIO ERNEST | Director | 6 | 2012–2013 | ||
| WILSON ROBERT N | Director | 3 | 2013 | ||
| CARROLL J MARTIN | Director | 3 | 2013 | ||
| Plutzky Jorge MD | Director | 19 | 2013–2020 | ||
| BIRO JON C | TenPercentOwnerOther | 2 | 2013 | ||
| DENNER ALEXANDER J | Director; DirectorOther; TenPercentOwnerOther | 6 | 2013–2015 | ||
| First BioMed Management Associates LLC | TenPercentOwnerOther | 1 | 2013 | ||
| FIRST MANHATTAN CO | TenPercentOwnerOther | 1 | 2013 | ||
| KEATING MELVIN L | TenPercentOwnerOther | 1 | 2013 | ||
| Norton David Y | Director; TenPercentOwnerOther | 19 | 2013–2020 | ||
| ROSENMAN HERM | Director; TenPercentOwnerOther | 23 | 2013–2020 | ||
| Sarissa Capital Domestic Fund LP | Other; TenPercentOwnerOther | 2 | 2013 | ||
| Sarissa Capital Management LP | Other; TenPercentOwnerOther | 2 | 2013 | ||
| Sarissa Capital Offshore Master Fund LP | Other; TenPercentOwnerOther | 2 | 2013 | ||
| Bass Rolf E. | TenPercentOwnerOther | 1 | 2013 | ||
| ASTRUE MICHAEL J | Director | 3 | 2013 | ||
| Colin Samuel F | Director; Director,TenPercentOwner | 4 | 2013–2014 | person page Fuzzy | |
| JOHANNES JACOB PIETER KASTELEIN | Director | 2 | 2013 | ||
| Zook Anthony P. | Director,Officer; Officer | Chief Executive Officer | 2 | 2013 | |
| Fischer Seth H. Z. | Director,Officer; Other | Chief Executive Officer | 10 | 2013–2018 | |
| Sanford Svai S | Officer | CFO & Chief Accounting Officer; Chief Financial Officer; Inter. Chief Financial Officer; Interim CFO | 7 | 2013–2015 | |
| Laughlin Conan | Director,TenPercentOwner; TenPercentOwner | 17 | 2015–2017 | ||
| NORTH TIDE CAPITAL, LLC | TenPercentOwner | 17 | 2015–2017 | ||
| North Tide Capital Master, LP | TenPercentOwner | 17 | 2015–2017 | ||
| Varghese Santosh T | Officer; Officer,TenPercentOwner | Chief Medical Officer; VP, Medical & Reg Affairs | 25 | 2015–2020 | |
| Roberts Eric W | Director | 37 | 2015–2019 | person page Fuzzy | |
| Shaw Allan | Director; DirectorOther | 37 | 2015–2018 | ||
| Sris Mayu | Director; Other | 12 | 2015–2017 | ||
| Mohamed Johann Noor | Officer | Interim CFO & Interim CAO | 1 | 2015 | person page Fuzzy |
| Oki Mark K | Officer | Chief Financial Officer & CAO; SVP, CFO, CAO | 12 | 2015–2020 | |
| KING THOMAS BRAXTON | Director; Director,Officer | Interim Chief Executive Office | 6 | 2017–2020 | |
| Amos John P. | Director,Officer | Chief Executive Officer | 11 | 2018–2020 | |
| Oehrlein M. Scott | Officer | Chief Operations Officer | 4 | 2018–2019 | |
| Suh Kenneth | Officer | President | 2 | 2018–2019 | |
| Ferrell Karen E. | Director | 2 | 2018–2020 | ||
| KANGAS EDWARD A | Director | 2 | 2018–2020 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | VIVUS LLC | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| SEC filer | VIVUS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Vivus Limited | State business registries | name and state | |
| Business registration | VIVUS LLC | State business registries | name and state | |
| Form 5500 plan sponsor | VIVUS LLC | EIN (EXACT) | ||
| Federal award recipient | VIVUS LLC | Federal spending (USAspending) | name and state | |
| Lobbying client | VIVUS INC | Federal lobbying (LDA) | name and state | |
| Lobbying client | VIVUS INC | Federal lobbying (LDA) | name and state | |
| Lobbying client | VIVUS INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | VIVUS, INC. | Federal lobbying (LDA) | name and state | |
| Person page | Eric W Roberts | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Johann Noor Mohamed | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Samuel F Colin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
- Regen BioPharma Inc CA
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- Diadexus, Inc. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health